Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...
Blockonomi

Novo Nordisk (NVO) Stock Gains After Company Exits $10 Billion Metsera Bidding War

Novo Nordisk stock rose 2.6% after withdrawing from a $10 billion bidding war for Metsera that investors viewed as too ...

Novo Nordisk shares rise on investor relief after it exits Metsera bid

Pedersen COPENHAGEN (Reuters) -Shares in Novo Nordisk rose on Monday after the Wegovy maker lost out to Pfizer in a $10 ...

Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle

Shares climbed as much as 3.5% in early European trade after Pfizer agreed to buy Metsera in a deal that could be worth more ...

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera.
Politiken

Novo Nordisk appears to have lost a major bidding war to Pfizer

Get the daily news here. Read the essential Danish news and topics of today - in English. Politiken Edition is your window to ...

Novo Nordisk Shares Rise After Dropping Metsera Bid

COPENHAGEN (Reuters) -Shares in Novo Nordisk rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its ...

Pfizer is losing its fight with Novo Nordisk to get back in the obesity-drug game

Shares of Pfizer Inc. gave up ground in early Tuesday trading, after the drug giant reported a decline in revenue, as ...

Notable healthcare headlines for the week: Pfizer, Novo Nordisk, Moderna in focus

Wall Street major averages posted weekly loses amid an AI-tech trade that continued to struggle, with lower consumer ...